|
1.
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Clark MJ, Homer N, O’Connor BD, Chen Z,
Eskin A, Lee H, Merriman B and Nelson SF: U87MG decoded: the
genomic sequence of a cytogenetically aberrant human cancer cell
line. PLoS Genet. 6:e10008322010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A,
Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO; European
Organisation for Research and Treatment of Cancer Brain Tumor and
Radiotherapy Groups; National Cancer Institute of Canada Clinical
Trials Group: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Fox SB, Turner GD, Gatter KC and Harris
AL: The increased expression of adhesion molecules ICAM-3,
E-selectin and P-selectins on breast cancer endothelium. J Pathol.
177:369–376. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nizamutdinova IT, Lee GW, Lee JS, Cho MK,
Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC and Kim
HJ: Tanshinone I suppresses growth and invasion of human breast
cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Carcinogenesis. 29:1885–1892. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Christiansen I, Sundstrom C and Totterman
TH: Elevated serum levels of soluble vascular cell adhesion
molecule-1 (sVCAM-1) closely reflect tumour burden in chronic
B-lymphocytic leukaemia. Br J Haematol. 103:1129–1137. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Maeda K, Kang SM, Sawada T, Nishiguchi Y,
Yashiro M, Ogawa Y, Ohira M, Ishikawa T, Hirakawa YS and Chung K:
Expression of intercellular adhesion molecule-1 and prognosis in
colorectal cancer. Oncol Rep. 9:511–514. 2002.PubMed/NCBI
|
|
8.
|
Becker JC, Dummer R, Hartmann AA, Burg G
and Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines
induced by IFN-gamma and tumor necrosis factor-alpha. Functional
consequences on cell-mediated cytotoxicity. J Immunol.
147:4398–4401. 1991.
|
|
9.
|
Osborn L, Hession C, Tizard R, Vassallo C,
Luhowskyj S, Chi-Rosso G and Lobb R: Direct expression cloning of
vascular cell adhesion molecule-1, a cytokine-induced endothelial
protein that binds to lymphocytes. Cell. 59:1203–1211. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kim HJ, Tsoy I, Park JM, Chung JI, Shin SC
and Chang KC: Anthocyanins from soybean seed coat inhibit the
expression of TNF-α-induced genes associated with
ischemia/reperfusion in endothelial cell by NF-κB-dependent pathway
and reduce rat myocardial damages incurred by ischemia and
reperfusion in vivo. FEBS Lett. 580:1391–1397. 2006.PubMed/NCBI
|
|
11.
|
Nizamutdinova IT, Oh HM, Min YN, Park SH,
Lee MJ, Kim JS, Yean MH, Kang SS, Kim YS, Chang KC and Kim HJ:
Paeonol suppresses intercellular adhesion molecule-1 expression in
tumor necrosis factor-α-stimulated human umbilical vein ECs by
blocking p38, ERK and nuclear factor-κB signaling pathways. Int
Immunopharmacol. 7:343–350. 2007.PubMed/NCBI
|
|
12.
|
Thompson EW and Price JT: Mechanisms of
tumour invasion and metastasis: emerging targets for therapy.
Expert Opin Ther Targets. 6:217–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Cavallaro U and Christofori G: Cell
adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Liou KT, Shen YC, Chen CF, Tsao CM and
Tsai SK: Honokiol protects rat brain from focal cerebral
ischemia-reperfusion injury by inhibiting neutrophil infiltration
and reactive oxygen species production. Brain Res. 992:159–166.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hibasami H, Achiwa Y, Katsuzaki H, Imai K,
Yoshioka K, Nakanishi K, Ishii Y, Hasegawa M and Komiya T: Honokiol
induces apoptosis in human lymphoid leukemia molt 4B cells. Int J
Mol Med. 2:671–673. 1998.PubMed/NCBI
|
|
17.
|
Yang SE, Hsieh MT, Tsai TH and Hsu SL:
Downmodulation of Bcl-XL, release of cytochrome c and sequential
activation of caspases during honokiol induced apoptosis in human
squamous lung cancer CH27 cells. Biochem Pharmacol. 63:1641–1651.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wang T, Chen F, Chen Z, Wu YF, Xu XL,
Zheng S and Hu X: Honokiol induces apoptosis through
p53-independent pathway in human colorectal cell line RKO. World J
Gastroenterol. 10:2205–2208. 2004.PubMed/NCBI
|
|
19.
|
Hirano T, Gotoh M and Oka K: Natural
flavonoids and lignans are potent cytostatic agents against human
leukemic HL-60 cells. Life Sci. 55:1061–1069. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Crane C, Panner A, Pieper RO, Arbiser J
and Parsa AT: Honokiol-mediated inhibition of PI3K/mTOR pathway: a
potential strategy to overcome immunoresistance in glioma, breast,
and prostate carcinoma without impacting T cell function. J
Immunother. 32:585–592. 2009. View Article : Google Scholar
|
|
21.
|
Wang X, Duan X, Yang G, Zhang X, Deng L,
Zheng H, Deng C, Wen J, Wang N, Peng C, Zhao X, Wei Y and Chen L:
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in
rat 9L intracerebral gliosarcoma model and human U251 xenograft
glioma model. PLoS One. 6:e184902011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Jeong JJ, Lee JH, Chang KC and Kim HJ:
Honokiol exerts an anticancer effect in T98G human glioblastoma
cells through the induction of apoptosis and the regulation of
adhesion molecules. Int J Oncol. 41:1358–1364. 2012.PubMed/NCBI
|
|
23.
|
Ponten J and Macintyre EH: Long term
culture of normal and neoplastic human glia. Acta Pathol Microbiol
Scand. 74:465–486. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Klemke M, Weschenfelder T, Konstandin MH
and Samstag Y: High affinity interaction of integrin alpha4beta1
(VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances
migration of human melanoma cells across activated endothelial cell
layers. J Cell Physiol. 212:368–374. 2007. View Article : Google Scholar
|
|
25.
|
Wu TC: The role of vascular cell adhesion
molecule-1 in tumor immune evasion. Cancer Res. 67:6003–6006. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Davis FG, Freels S, Grutsch J, Barlas S
and Brem S: Survival rates in patients with primary malignant brain
tumors stratified by patient age and tumor histological type:
analysis based on surveillance, epidemiology and end results (SEER)
data, 1973–1991. J Neurosurg. 88:11998.PubMed/NCBI
|
|
27.
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
28.
|
Moon SH and Park KS: Enrichment of cancer
stem cell of glioblastoma by neurosphere formation. Tissue Eng
Regenerative Med. 9:40–47. 2012.
|
|
29.
|
Dejana E, Orsenigo F and Lampugnani MG:
The role of adherens junctions and VE-cadherin in the control of
vascular permeability. J Cell Sci. 121:2115–2122. 2008. View Article : Google Scholar : PubMed/NCBI
|
